“…Estimates of the prevalence of adrenal dysfunction among critically ill patients vary widely, from 0.66 to over 40%, depending on the definition of adrenal dysfunction and the specific patient population studied (3,6,9,25,35,36,40). Drugs administered to such patients may contribute to adrenal dysfunction by increasing the rate at which cortisol is metabolized (20) or, as in the case of etomidate (8,46) or ketoconazole (26,30,33,34), by inhibiting enzymes in the steroid biosynthetic pathway.…”